Recent Finacing
Recent Raise
Bonti is a clinical-stage biotech developing EB-001, a BoNT/E with ~24-hour onset and ~3–4-week duration for aesthetic and musculoskeletal pain indications; conducting Phase 2 trials and regulatory planning.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Bonti.
